Radioactive scanning agents with stabilizer
AssigneeThe Procter & Gamble Company
InventorMahdi B. Fawzi
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Procter & Gamble Company
InventorMahdi B. Fawzi
Estimating the term…
Stable compositions, useful as technetium-99m-based scintigraphic agents, comprise gentisyl alcohol or a pharmaceutically-acceptable salt or ester thereof in combination with a pertechnetate reducing agent or dissolved in pertechnetate-99m (.sup.99m TcO.sub.4.sup.-) solution. The compositions are especially useful in combination with a phosphate or phosphonate material which carries the radionuclide to bone, thus providing a skeletal imaging agent.
A stable composition, useful in the preparation of technetium-99 m-based radiographic scanning agents, comprising:
A composition useful in the preparation of technetium-99 m-based radiographic scanning agents, comprising:
A method of preparing a stabilized technetium-99 m-based scanning agent, comprising codissolving a stabilizing amount of a gentisol stabilizer selected from gentisyl alcohol or a pharmaceutically-acceptable salt or ester thereof with an aqueous solution of radioactive technetium in the +3, +4 or +5 valence state.
Dependencies are inferred from the claim text.
Drawings are temporarily unavailable. Open the PDF at USPTO
No related US applications are recorded in the indexed filing history.
Characterised by the carrier , i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus: inorganic Tc…
Characterised by the carrier , i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus: organic compounds
Preparations containing radioactive substances for use in therapy or testing in vivo: characterised by a special physical form, e.g. emulsion,…
Preparations for testing in vivo
Term ended 28 Jun 1998 (estimated)
USPTO file history isn’t available for this patent, so only indexed dates are shown.
This invention relates to compositions useful in the preparation of stable scintigraphic scanning (or, "radiodiagnostic") agents employing technetium-99m. More particularly, gentisyl alcohol (or soluble gentisyl alcohol compound) is used as a non-interfering stabilizer for such compositions.
Scintigraphy and similar radiographic techniques are finding ever increasing application in biological and medical research and diagnostic procedures. In general, scintigraphy procedures involve the preparation of radioactive scanning agents which, upon introduction into a biological subject, become localized in specific organs, tissue or skeletal material which are under study. When so localized, traces, plots or scintiphotos of the distribution of the radioactive material can be made by various radiation detectors, i.e., such as traversing scanners, scintillation cameras and the like. The resultant distribution and corresponding relative intensities can then be used to indicate the position occupied by the tissue in which the radionuclide is localized as well as indicate the presence of aberrations, pathological conditions, and the like.
In general, and depending on the type of radionuclide used and the organ of interest, a scintigraphic scanning agent as used in the hospital comprises a radionuclide, a carrier agent designed to target the specific organ, various auxiliary agents which affix the radionuclide to the carrier, water or other delivery vehicle suitable for injection into, or aspiration by, the patient, physiologic buffers and salts, and the like.